Abstract
Objective
99mTc-Evans Blue (EB) is an agent that contains both radioactive and color signals in a single dose. Earlier studies in animal models have suggested that this agent when compared with the dual-injection technique of radiocolloid/blue dye can successfully discriminate the sentinel lymph node. The aim of this study was to investigate the potential of 99mTc-EB as an agent to map the lymphatic system in an ovine model.
Methods
Doses of 99mTc-EB (23 MBq) containing EB dye (4 mg) were administered intradermally to the limbs of four anesthetized sheep, and they were then imaged over 20–30 min using a gamma camera. The study protocol was repeated using 99mTc-antimony trisulfide colloid (ATC) and Patent Blue V dye. The lymph nodes (popliteal, inguinal, and iliac for hind limbs or prescapular for fore limbs) were identified with a gamma probe during the operative exposure, then dissected and counted in a large volume counter.
Results
Simple and complex (dual) drainage patterns were visible on the scans, and the sentinel node was more radioactive than higher tier nodes in a chain, for both radiotracers. For 99mTc-EB, maximum radioactive uptake was achieved at 3–6 min for popliteal lymph nodes, 12–14 min for iliac nodes, and 13–14 min for prescapular nodes. 99mTc-ATC resulted in maximum radioactive uptake at 4–6 min for popliteal lymph nodes, 13 min for an inguinal node, 13–20 min for iliac nodes, and 18 min for a prescapular node. Following 99mTc-EB injection, 15/15 lymph nodes harvested were all radioactive and blue. For 99mTc-radiocolloid/Patent Blue V injection, 8/14 nodes were radioactive and blue, and 6/14 nodes were radioactive only.
Conclusions
The soluble radiotracer 99mTc-EB appeared to be a useful lymphoscintigraphic agent in sheep, in which radioactive counts from superficial lymphatic channels and lymph nodes were sufficient for planar imaging. In comparison with 99mTc-antimony trisulfide colloid, both tracers discriminated the sentinel lymph node up to 50 min after administration; however, 99mTc-EB had the advantage of providing radioactive (gamma probe) and color signals simultaneously during the operative exposure.
Similar content being viewed by others
References
Alazraki NP, Eshima D, Eshima LA, Herda SC, Murray DR, Vansant JP, et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med 1997;27:55–67.
Tsopelas C. Particle size analyses of 99mTc-labelled and unlabelled rhenium sulfide and antimony trisulphide colloids intended for application in lymphoscintigraphic studies. J Nucl Med 2001;42:467–475.
Bajen MT, Benitez A, Mora J, Ricart Y, Ferran N, Guirao S, et al. Subdermal re-injection: a method to increase surgical detection of the sentinel node in breast cancer without increasing the false-negative rate. Eur J Nucl Med Mol Imaging 2006;33:338–343.
Motomura K, Inaji H, Komoike Y, Hasegawa Y, Kasugai T, Noguchi S, et al. Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol 2001;76:95–99.
Scarsbrook AF, Ganeshan A, Bradley KM. Pearls and pitfalls of radionuclide imaging of the lymphatic system. Part 1: sentinel node lymphoscintigraphy in malignant melanoma. Br J Radiol 2006. doi 10.1259/bjr/20286459.
Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368–373.
Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130:654–658.
Wong JH, Cagle LA, Morton DL. Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 1991;214:637–641.
Kennedy RJ, Kollias J, Gill PG, Bochner M, Coventry BJ, Farshid G. Removal of two sentinel nodes accurately stages the axilla in breast cancer. Br J Surg 2003;90:1349–1353.
Bobin JY, Spirito C, Isaac S, Zinzindohoue C, Joualee A, Khaled M, et al. Lymph node mapping and axillary sentinel lymph node biopsy in 243 invasive breast cancers with no palpable nodes: the south Lyon hospital center experience. Ann Chir 2000;125:861–870.
Park DJ, Lee HJ, Lee HS, Kim WH, Kim HH, Lee KU, et al. Sentinel node biopsy for cT1 and cT2a gastric cancer. Eur J Surg Oncol 2006;32:48–54.
Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 2001;192:684–689.
Nathanson SD, Wachna DL, Gilman D, Karvelis K, Havstad S, Ferrara J. Pathways of lymphatic drainage from the breast. Ann Surg Oncol 2001;8:821–827.
Takei H, Suemasu K, Kurosumi M, Horii Y, Ninomiya J, Kamimura M, et al. Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer. Breast Cancer 2006;13:179–185.
Tsopelas C, Penglis S. Visualisation of lymphatic flow in a rabbit model using 99mTc-labelled dyes. Hell J Nucl Med 2000;3:96–101.
Lin B, Yang Z, Zhao C. 99mTc-labelled blue Ficoll as a tracer for the localization of sentinel nodes (abstract). J Nucl Med 2002;43:368 p.
El-Tamer M, Saouaf R, Wang T, Fawwaz R. A new agent, blue and radioactive, for sentinel node detection. Ann Surg Oncol 2003;10:323–329.
Stafford SJ, Wright JL, Schwimer J, Anthony CT, Cundiff JD, Thomson JL, et al. Development of 125I-methylene blue for sentinel lymph node biopsy. J Surg Oncol 2006;94:293–297.
Tsopelas C. Technetium-99m labeling of a molecule bearing easily reducible groups. Nucl Med Biol 2000;27:797–802.
Bernstein IM, Ziegler W, Badger GJ. Plasma volume expansion in early pregnancy. Obstet Gynecol 2001;97:669–672.
Sutton R, Tsopelas C, Chatterton B, Coventry B, Kollias J. Sentinel node biopsy and lymphoscintigraphy with a technetium 99m labeled blue dye in a rabbit model. Surgery 2002;131:44–49.
Tsopelas C, Bevington E, Kollias J, Shibli S, Farshid G, Coventry C, et al. 99mTc-Evans Blue dye for mapping contiguous lymph node sequences and discriminating the sentinel lymph node in an ovine model. Ann Surg Oncol 2006;13:692–700.
Ohtani O, Ohtani Y, Carati CJ, Gannon BJ. Fluid and cellular pathways of rat lymph nodes in relation to lymphatic labyrinths and Aquaporin-1 expression. Arch Histol Cytol 2003;66:261–272.
Tsopelas C. Lymphoscintigraphic evaluation of high specific activity 99mTc-antimony trisulphide colloid (ATC) in rats. J Labelled Comp Radiopharm 2003;46:S330.
Ikomi F, Hanna GK, Schmid-Schönbein GW. Mechanism of colloidal particle uptake into the lymphatic system: basic study with percutaneous lymphography. Radiology 1995;196:107–113.
Green M, Farshid G, Kollias J, Chatterton BE, Tsopelas C. The tissue distribution of Evans Blue Dye in a sheep model of sentinel node biopsy. Nucl Med Commun 2006;27:695–700.
Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med 1998;39:1185–1190.
Green M, Kollias J, Chatterton BE, Tsopelas C. Identification of the sentinel lymph node in patients with invasive breast cancer using 99mTc-Evans Blue dye (abstract). Intern Med J 2005;35:E26.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsopelas, C., Bellon, M., Bevington, E. et al. Lymphatic mapping with 99mTc-Evans Blue dye in sheep. Ann Nucl Med 22, 777–785 (2008). https://doi.org/10.1007/s12149-008-0171-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-008-0171-y